Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H6O4S |
| Molecular Weight | 126.132 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOS(O)(=O)=O
InChI
InChIKey=KIWBPDUYBMNFTB-UHFFFAOYSA-N
InChI=1S/C2H6O4S/c1-2-6-7(3,4)5/h2H2,1H3,(H,3,4,5)
| Molecular Formula | C2H6O4S |
| Molecular Weight | 126.132 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21616946
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21616946
Ethyl sulfate is a metabolite of ethanol and a biomarker of recent alcohol consumption that provide objective measures of abstinence.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Value of Ethyl Glucuronide and Ethyl Sulfate in Serum as Biomarkers of Alcohol Consumption. | 2017-08-31 |
|
| Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. | 2014-07 |
|
| Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. | 2011-05-28 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:18:55 GMT 2025
by
admin
on
Mon Mar 31 19:18:55 GMT 2025
|
| Record UNII |
P3LK0HF3B7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ETHYL SULFATE
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
P3LK0HF3B7
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
208-758-6
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
DTXSID10862151
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
6004
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
m5174
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
P3LK0HF3B7
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
540-82-9
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | |||
|
1665664
Created by
admin on Mon Mar 31 19:18:55 GMT 2025 , Edited by admin on Mon Mar 31 19:18:55 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |